# Crescent Capital BDC, Inc.: financial statements, quarterly

CCAP · Nasdaq · CIK 1633336 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccap.md) · [Financials](/companies/ccap/financials.md) · [Filings](/companies/ccap/filings.md) · [Insiders](/companies/ccap/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccap/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(26.1)](/filings/0000950170-24-124474.md) | [(26.8) d](/filings/0001193125-26-071922.md) | [(26.7)](/filings/0000950170-25-071368.md) | [(26.8)](/filings/0000950170-25-108024.md) | [(27.4)](/filings/0001193125-25-277533.md) | [(25.8) d](/filings/0001193125-26-071922.md) | [(25.0)](/filings/0001193125-26-221936.md) | [(25.7)](/filings/0001193125-26-342351.md) | [(24.1)](/filings/0001193125-25-277533.md) | [(23.8) d](/filings/0001193125-26-071922.md) | [(21.9)](/filings/0001193125-26-221936.md) | [(22.7)](/filings/0001193125-26-342351.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0000950170-25-108024.md) | [0.2](/filings/0001193125-25-277533.md) | [0.0 d](/filings/0001193125-26-071922.md) | [0.0](/filings/0001193125-26-221936.md) | [0.0](/filings/0001193125-26-342351.md) | [0.0](/filings/0001193125-25-277533.md) | [0.0 d](/filings/0001193125-26-071922.md) | not reported | [0.0](/filings/0001193125-26-342351.md) |
| Net income | $m | [22.6](/filings/0000950170-24-124474.md) | [30.9 d](/filings/0001193125-26-071922.md) | [28.0](/filings/0000950170-25-071368.md) | [20.4](/filings/0000950170-25-108024.md) | [15.3](/filings/0001193125-25-277533.md) | [10.0 d](/filings/0001193125-26-071922.md) | [3.9](/filings/0001193125-26-221936.md) | [15.0](/filings/0001193125-26-342351.md) | [7.1](/filings/0001193125-25-277533.md) | [8.5 d](/filings/0001193125-26-071922.md) | [(15.5)](/filings/0001193125-26-221936.md) | [(3.2)](/filings/0001193125-26-342351.md) |
| Diluted EPS | $ per share | [0.59](/filings/0000950170-24-124474.md) | not reported | [0.63](/filings/0000950170-25-071368.md) | [0.59](/filings/0000950170-25-108024.md) | [0.64](/filings/0001193125-25-277533.md) | not reported | [0.45](/filings/0001193125-26-221936.md) | [0.46](/filings/0000950170-25-108024.md) | [0.46](/filings/0001193125-25-277533.md) | not reported | [0.42](/filings/0001193125-26-221936.md) | not reported |
| Basic EPS | $ per share | [0.59](/filings/0000950170-24-124474.md) | not reported | [0.63](/filings/0000950170-25-071368.md) | [0.59](/filings/0000950170-25-108024.md) | [0.64](/filings/0001193125-25-277533.md) | not reported | [0.45](/filings/0001193125-26-221936.md) | [0.46](/filings/0000950170-25-108024.md) | [0.46](/filings/0001193125-25-277533.md) | not reported | [0.42](/filings/0001193125-26-221936.md) | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.0](/filings/0000950170-23-061089.md) | [7.8](/filings/0000950170-25-023153.md) | [6.7](/filings/0000950170-24-055626.md) | [11.0](/filings/0000950170-24-095458.md) | [17.1](/filings/0000950170-24-124474.md) | [10.1](/filings/0001193125-26-071922.md) | [12.0](/filings/0001193125-26-221936.md) | [9.7](/filings/0001193125-26-342351.md) | [5.8](/filings/0001193125-25-277533.md) | [5.0](/filings/0001193125-26-342351.md) | [6.1](/filings/0001193125-26-221936.md) | [15.6](/filings/0001193125-26-342351.md) |
| Total assets | $m | [1,624](/filings/0000950170-23-061089.md) | [1,627](/filings/0000950170-25-023153.md) | [1,620](/filings/0000950170-24-055626.md) | [1,672](/filings/0000950170-24-095458.md) | [1,645](/filings/0000950170-24-124474.md) | [1,656](/filings/0001193125-26-071922.md) | [1,666](/filings/0000950170-25-071368.md) | [1,654](/filings/0000950170-25-108024.md) | [1,628](/filings/0001193125-25-277533.md) | [1,622](/filings/0001193125-26-342351.md) | [1,618](/filings/0001193125-26-221936.md) | [1,619](/filings/0001193125-26-342351.md) |
| Total liabilities | $m | [894](/filings/0000950170-23-061089.md) | [885](/filings/0000950170-25-023153.md) | [869](/filings/0000950170-24-055626.md) | [920](/filings/0000950170-24-095458.md) | [896](/filings/0000950170-24-124474.md) | [916](/filings/0001193125-26-071922.md) | [939](/filings/0000950170-25-071368.md) | [930](/filings/0000950170-25-108024.md) | [914](/filings/0001193125-25-277533.md) | [916](/filings/0001193125-26-342351.md) | [944](/filings/0001193125-26-221936.md) | [962](/filings/0001193125-26-342351.md) |
| Long-term debt | $m | [857](/filings/0000950170-23-061089.md) | [845](/filings/0000950170-25-023153.md) | [831](/filings/0000950170-24-055626.md) | [880](/filings/0000950170-24-095458.md) | [857](/filings/0000950170-24-124474.md) | [876](/filings/0001193125-26-071922.md) | [903](/filings/0000950170-25-071368.md) | [887](/filings/0000950170-25-108024.md) | [875](/filings/0001193125-25-277533.md) | [874](/filings/0001193125-26-342351.md) | [907](/filings/0001193125-26-221936.md) | [923](/filings/0001193125-26-342351.md) |
| Shareholders' equity | $m | [730](/filings/0000950170-24-124474.md) | [743](/filings/0001193125-26-071922.md) | [752](/filings/0000950170-25-108024.md) | [752](/filings/0001193125-25-277533.md) | [749](/filings/0001193125-25-277533.md) | [741](/filings/0001193125-26-342351.md) | [727](/filings/0001193125-26-342351.md) | [725](/filings/0001193125-26-342351.md) | [714](/filings/0001193125-25-277533.md) | [706](/filings/0001193125-26-342351.md) | [674](/filings/0001193125-26-342351.md) | [656](/filings/0001193125-26-342351.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.4 d](/filings/0000950170-24-124474.md) | [34.6 d](/filings/0001193125-26-071922.md) | [39.5](/filings/0000950170-25-071368.md) | [(24.6) d](/filings/0000950170-25-108024.md) | [46.9 d](/filings/0001193125-25-277533.md) | [(2.9) d](/filings/0001193125-26-071922.md) | [(15.1)](/filings/0001193125-26-221936.md) | [36.4 d](/filings/0001193125-26-342351.md) | [30.8 d](/filings/0001193125-25-277533.md) | [22.6 d](/filings/0001193125-26-071922.md) | [(23.8)](/filings/0001193125-26-221936.md) | [9.8 d](/filings/0001193125-26-342351.md) |
| Dividends paid | $m | [18.2 d](/filings/0000950170-24-124474.md) | [18.5 d](/filings/0001193125-26-071922.md) | [18.9](/filings/0000950170-25-071368.md) | [19.3 d](/filings/0000950170-25-108024.md) | [18.9 d](/filings/0001193125-25-277533.md) | [18.2 d](/filings/0001193125-26-071922.md) | [17.4](/filings/0001193125-26-221936.md) | [17.4 d](/filings/0001193125-26-342351.md) | [17.4 d](/filings/0001193125-25-277533.md) | [15.6 d](/filings/0001193125-26-071922.md) | [15.5](/filings/0001193125-26-221936.md) | [16.6 d](/filings/0001193125-26-342351.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.0 d](/filings/0001193125-26-071922.md) | [1.0](/filings/0001193125-26-221936.md) | [0.7 d](/filings/0001193125-26-342351.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.9](/filings/0000950170-23-061089.md) | [32.5](/filings/0000950170-24-055626.md) | [37.1](/filings/0000950170-24-095458.md) | [37.1](/filings/0000950170-24-124474.md) | [37.1](/filings/0000950170-25-071368.md) | [37.1](/filings/0000950170-25-108024.md) | [37.1](/filings/0001193125-25-277533.md) | [37.1](/filings/0001193125-26-221936.md) | [37.1](/filings/0001193125-26-342351.md) | [37.1](/filings/0001193125-25-277533.md) | [36.9](/filings/0001193125-26-221936.md) | [36.9](/filings/0001193125-26-342351.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,845,952 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342351.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.